Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-4083 Capsules When Given Alone or In Combination With Albendazole Capsules Moves in The Body of Adult Participants With Onchocerca Volvulus Infection
Clinical trial NCT04913610 · TERMINATED
Trial details
- NCT number
- NCT04913610
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-22
- Primary completion
- 2023-08-29
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.